Adult T-Cell Leukemia/Lymphoma · line 1 · AZT (zidovudine) + IFN-α — continuous, dose-adjusted

Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.

Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.

Source YAML: complete record

Line of therapy	1
Track	standard
Linked regimen	`REG-AZT-IFN-A`

ID	`IND-ATLL-1L-INDOLENT-AZT-IFN`
Type	Indication
Status	reviewed 2026-04-25 \| pending_clinical_signoff
Diseases	`DIS-ATLL`
Sources	`SRC-NCCN-BCELL-2025`

Notes

STUB. Тільки для chronic + smoldering subtypes. Acute / lymphoma → IND-ATLL-1L-AGGRESSIVE-MLSG15.

Used By

Algorithms

ALGO-ATLL-1L - ALGO-ATLL-1L

Contraindications

CI-PSYCH-DECOMPENSATED-FOR-INTERFERON - CI-PSYCH-DECOMPENSATED-FOR-INTERFERON